Plantar fasciitis. Diseases of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention 1: First intervention group: injection 0f a combination of 1 cc methylprednisolone 40 mg and 1 cc salin 0.9%. Intervention 2: Second intervention group: injection of 2 cc of dextrose 20%.
Treatment - Drugs
Second intervention group: injection of 2 cc of dextrose 20%
Sponsors
Vice Chancellor for research of Iran University Of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion: a history of plantar fasciitis;heel pain for more than 2 months with a VAS(visual Analogue Scale) more than 4;fascia hypoechogenisity and thickness more than 4 mm in sonography exclusion:a history of direct trauma; positive tinnel sign; a history of systemic inflamatory or soft tissue diseases; disk herniation with S1 radiculopathy; a history of gout; diabetes melitus; a history of surgury or injection in fascia since 6 months ago, existence of cyst/mass in pain site; coincidence of paresthesia or numbness; coagolupathy; pregnancy; hypersensitivity to corticosteroids; infection of injection site, posterior heel pain; any treatment for the condition since 4 weeks ago; patients who receive physiotherapy, splint, Ionophoresis and shockwave during 2 months after injection
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before injection, 2 weeks and 8 weeks after injection. Method of measurement: Visual Analog Scale(VAS).;Daily living and sport activity. Timepoint: before injection,2 weeks and 8 weeks after injection. Method of measurement: FAAM questionaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Thickness of plantar fascia. Timepoint: before injection, 2 weeks and 8 weeks after injection. Method of measurement: sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmin Arbabi
Firoozgar hospital
Outcome results
None listed